Finerenone in the management of diabetes kidney disease

Abstract People with type 2 diabetes are at risk of developing progressive diabetic kidney disease (DKD) and end stage kidney failure. Hypertension is a major, reversible risk factor in people with diabetes for development of albuminuria, impaired kidney function, end-stage kidney disease and cardio...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Parijat De, May T Khine, Andrew Frankel, Gabrielle Goldet, Debasish Banerjee, Rosa M Montero, Tahseen A Chowdhury, Damien Fogarty, Janaka Karalliedde, Ritwika Mallik, Dipesh C Patel, Mona Wahba, Peter Winocour, Sagen Zac-Varghese, Stephen Bain, Adnan Sharif, Srikanth Bellary, Indranil Dasgupta
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-02-01
Serija:	BMC Nephrology
Teme:	Diabetes Hypertension Albuminuria Diabetic kidney disease Finerenone ACE inhibitors
Online dostop:	https://doi.org/10.1186/s12882-025-03985-9
Oznake:	Označite Brez oznak, prvi označite!